MAPT and Alzheimer disease: Intermittent fasting, despite ameliorating cognitive decline, has no effect on Aβ levels or tau phosphorylation in mice, leading to the hypothesis that the neuro-protective effects of IF act downstream of these pathologies in AD (Halagappa et al., 2007).